Profile | GDS5420 / 203614_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 893 | 77 |
GSM1296119 | B_lesional_pre-dose | 1675.49 | 87 |
GSM1296076 | C_lesional_pre-dose | 1860.45 | 87 |
GSM1296092 | D_lesional_pre-dose | 1884.8 | 88 |
GSM1296103 | E_lesional_pre-dose | 1128.71 | 81 |
GSM1296078 | F_lesional_pre-dose | 1500.99 | 84 |
GSM1296107 | G_lesional_pre-dose | 1496.58 | 85 |
GSM1296109 | H_lesional_pre-dose | 1161.35 | 82 |
GSM1296080 | I_lesional_pre-dose | 854.28 | 76 |
GSM1296090 | J_lesional_pre-dose | 2049.63 | 89 |
GSM1296074 | K_lesional_pre-dose | 2020.8 | 88 |
GSM1296111 | L_lesional_pre-dose | 1723.04 | 87 |
GSM1296099 | M_lesional_pre-dose | 1192.24 | 82 |
GSM1296086 | O_lesional_pre-dose | 1597.74 | 86 |
GSM1296117 | P_lesional_pre-dose | 1816.96 | 88 |
GSM1296113 | Q_lesional_pre-dose | 1979.57 | 90 |
GSM1296096 | R_lesional_pre-dose | 1207.9 | 82 |
GSM1296105 | S_lesional_pre-dose | 1034.08 | 80 |
GSM1296098 | T_lesional_pre-dose | 777 | 75 |
GSM1296101 | U_lesional_pre-dose | 818.89 | 76 |
GSM1296121 | V_lesional_pre-dose | 1629.3 | 86 |
GSM1296088 | W_lesional_pre-dose | 1290.91 | 83 |
GSM1296082 | X_lesional_pre-dose | 1449.69 | 84 |
GSM1296115 | Y_lesional_pre-dose | 1537.66 | 86 |
GSM1296084 | Z_lesional_pre-dose | 1438.07 | 85 |
GSM1296072 | B_lesional_day8 | 1781.48 | 88 |
GSM1296069 | L_lesional_day8 | 1774.89 | 88 |
GSM1296071 | P_lesional_day8 | 1743.93 | 88 |
GSM1296070 | Y_lesional_day8 | 1654.93 | 87 |
GSM1296073 | V_lesional_day8 | 1864.85 | 88 |
GSM1296034 | A_lesional_day15 | 759.03 | 74 |
GSM1296041 | G_lesional_day15 | 1569.56 | 86 |
GSM1296035 | R_lesional_day15 | 1479.53 | 85 |
GSM1296038 | U_lesional_day15 | 1310.03 | 83 |
GSM1296047 | B_lesional_day15 | 2030.92 | 90 |
GSM1296039 | E_lesional_day15 | 1451.17 | 85 |
GSM1296042 | H_lesional_day15 | 1669.4 | 87 |
GSM1296043 | L_lesional_day15 | 1536.19 | 86 |
GSM1296037 | M_lesional_day15 | 1631.85 | 87 |
GSM1296046 | P_lesional_day15 | 1921.96 | 90 |
GSM1296044 | Q_lesional_day15 | 2039.69 | 90 |
GSM1296045 | Y_lesional_day15 | 1831.75 | 89 |
GSM1296025 | C_lesional_day15 | 1199.72 | 82 |
GSM1296033 | D_lesional_day15 | 1669.68 | 87 |
GSM1296027 | I_lesional_day15 | 1611.07 | 86 |
GSM1296032 | J_lesional_day15 | 1996.13 | 89 |
GSM1296024 | K_lesional_day15 | 1682.38 | 87 |
GSM1296031 | W_lesional_day15 | 1221.61 | 82 |
GSM1296028 | X_lesional_day15 | 1504.61 | 85 |
GSM1296029 | Z_lesional_day15 | 1579.78 | 86 |
GSM1296026 | F_lesional_day15 | 1328.7 | 83 |
GSM1296030 | O_lesional_day15 | 1428.59 | 84 |
GSM1296040 | S_lesional_day15 | 858.69 | 77 |
GSM1296036 | T_lesional_day15 | 1130.93 | 81 |
GSM1296048 | V_lesional_day15 | 1815.36 | 88 |
GSM1296059 | A_lesional_day43 | 1302.02 | 83 |
GSM1296066 | G_lesional_day43 | 1499.65 | 85 |
GSM1296060 | R_lesional_day43 | 1360.81 | 84 |
GSM1296063 | U_lesional_day43 | 1463.76 | 85 |
GSM1296064 | E_lesional_day43 | 1782.69 | 87 |
GSM1296067 | H_lesional_day43 | 1604.53 | 87 |
GSM1296062 | M_lesional_day43 | 1007.51 | 79 |
GSM1296068 | Q_lesional_day43 | 2145.09 | 91 |
GSM1296050 | C_lesional_day43 | 1891.31 | 88 |
GSM1296057 | D_lesional_day43 | 1717.43 | 87 |
GSM1296052 | I_lesional_day43 | 1701.99 | 87 |
GSM1296054 | J_lesional_day43 | 1497.21 | 86 |
GSM1296049 | K_lesional_day43 | 1453.37 | 85 |
GSM1296055 | W_lesional_day43 | 1562 | 86 |
GSM1296053 | X_lesional_day43 | 986.57 | 79 |
GSM1296058 | Z_lesional_day43 | 1666.99 | 87 |
GSM1296051 | F_lesional_day43 | 1498.72 | 85 |
GSM1296056 | O_lesional_day43 | 1422.48 | 84 |
GSM1296065 | S_lesional_day43 | 1560 | 86 |
GSM1296061 | T_lesional_day43 | 1047.45 | 80 |
GSM1296095 | A_non-lesional_pre-dose | 1490.04 | 85 |
GSM1296120 | B_non-lesional_pre-dose | 1929.13 | 89 |
GSM1296077 | C_non-lesional_pre-dose | 2046.2 | 89 |
GSM1296093 | D_non-lesional_pre-dose | 1174.3 | 82 |
GSM1296104 | E_non-lesional_pre-dose | 1613.57 | 86 |
GSM1296079 | F_non-lesional_pre-dose | 1498.9 | 85 |
GSM1296108 | G_non-lesional_pre-dose | 1850.35 | 88 |
GSM1296110 | H_non-lesional_pre-dose | 1537.17 | 86 |
GSM1296081 | I_non-lesional_pre-dose | 1387.94 | 84 |
GSM1296091 | J_non-lesional_pre-dose | 2317.54 | 91 |
GSM1296075 | K_non-lesional_pre-dose | 2432.5 | 91 |
GSM1296112 | L_non-lesional_pre-dose | 1543.55 | 87 |
GSM1296100 | M_non-lesional_pre-dose | 1390.6 | 84 |
GSM1296087 | O_non-lesional_pre-dose | 1832.03 | 87 |
GSM1296118 | P_non-lesional_pre-dose | 2183.78 | 91 |
GSM1296114 | Q_non-lesional_pre-dose | 2197.17 | 91 |
GSM1296097 | R_non-lesional_pre-dose | 1048.25 | 80 |
GSM1296106 | S_non-lesional_pre-dose | 1058.03 | 80 |
GSM1296102 | U_non-lesional_pre-dose | 1123.58 | 81 |
GSM1296122 | V_non-lesional_pre-dose | 1948.71 | 89 |
GSM1296089 | W_non-lesional_pre-dose | 1547.94 | 86 |
GSM1296083 | X_non-lesional_pre-dose | 1056.95 | 80 |
GSM1296116 | Y_non-lesional_pre-dose | 1734.81 | 88 |
GSM1296085 | Z_non-lesional_pre-dose | 1621.54 | 86 |